Latest Insider Transactions at Bicara Therapeutics Inc. (BCAX)
This section provides a real-time view of insider transactions for Bicara Therapeutics Inc. (BCAX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bicara Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bicara Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2024
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
70,000
+3.75%
|
$1,260,000
$18.0 P/Share
|
|
Sep 17
2024
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,725,174
+50.0%
|
-
|
|
Sep 16
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,833,000
+16.76%
|
$32,994,000
$18.0 P/Share
|
|
Sep 16
2024
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
5,122,993
+50.0%
|
-
|
|
Sep 16
2024
|
Tpg Gp A, LLC |
BUY
Conversion of derivative security
|
Indirect |
1,960,425
+50.0%
|
-
|
|
Sep 16
2024
|
Fil LTD |
BUY
Conversion of derivative security
|
Indirect |
1,013,853
+41.23%
|
-
|
|
Sep 16
2024
|
Fmr LLC |
BUY
Conversion of derivative security
|
Indirect |
1,115,333
+41.88%
|
-
|
|
Sep 16
2024
|
Kiran Mazumdar Shaw |
BUY
Conversion of derivative security
|
Indirect |
6,165,428
+49.84%
|
-
|
|
Sep 16
2024
|
Biocon LTD |
BUY
Conversion of derivative security
|
Indirect |
5,408,140
+49.67%
|
-
|